Palisade Bio, Inc. (PALI)
1.73
-0.01
(-0.57%)
USD |
NASDAQ |
Feb 13, 16:00
1.745
+0.02
(+0.87%)
After-Hours: 20:00
Palisade Bio EPS Diluted (Quarterly) : -0.3837 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Amicus Therapeutics, Inc. | 0.0558 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.868M |
| Total Expenses (Quarterly) | 2.868M |
| Enterprise Value | 253.11M |
| Earnings Yield | -243.9% |
| Normalized Earnings Yield | -250.98 |